China Immunotech (Beijing) Biotechnology Co., Ltd.
4 clinical trials · 4 recruiting · INDUSTRY
Trials by China Immunotech (Beijing) Biotechnology Co., Ltd.
RECRUITINGPhase 1NCT07236801
Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 182 locations
Systemic Lupus Erythematosus (SLE)Systemic SclerosisSjogren's Syndrome (SS)+3
RECRUITINGNCT06379646
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
An exploratory clinical study of the safety and efficacy of YTS109 cell injection in subjects with recurrent/refractory autoimmune disease
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 61 location
Systemic Lupus ErythematosusSystemic SclerosisInflammatory Myopathy+3
RECRUITINGPhase 1NCT07104721
A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 181 location
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Systemic Sclerosis (SSc)+3
RECRUITINGPhase 1NCT07123519
A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
This study evaluates the safety and efficacy of YTS109 cells in adults with relapsed/refractory autoimmune diseases, such as Systemic Lupus Erythematosus (SLE), including LN and...
Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd.Enrolling: 181 location
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)Sjogren's Syndrome (SS)+3